Von Recklinghausen neurofibromatosis (NF1), one of the most common human autosomal dominant conditions, is characterized by cafe-au- lait spots, neurofibromas, Lisch nodules of the iris, and a variety of other manifestations. This locus has one of the highest spontaneous mutation rates recorded, about 10-4/allele/generation. In the three short years since the submission of our original proposal to initiate linkage studies in NF1, the gene has been mapped using RFLP markers to the proximal long arm of chromosome 17, through the efforts of our group and others. We now propose additional molecular approaches which should lead to the cloning and characterization of the NF1 gene. Specifically, we intend to refine the linkage analysis of our 21 NF1 families using multipoint methods, and to construct ordered genetic maps of less than 1 cM resolution by subjecting individual sperm to amplification of marker loci using the polymerase chain reaction (PCR). We will also construct a complete physical map of proximal 17q using pulsed field gel electrophoresis and libraries containing DNA fragments which include a rear restriction site (so-called linking libraries). Besides allowing the connection of parts of the physical map, these also provide entry points into chromosome jumping libraries. Importantly, a powerful set of somatic cell hybrids is available to allow the construction and mapping of such linking clones to the desired region of chromosome 17. A major question with this """"""""reverse genetics"""""""" approach is how to identify the gene itself. Fortunately, we have available cell lines from two NF1 patients who carry balanced translocations involving 17q11. It is highly likely that the NF1 gene is disrupted by these translocations, so that identification and cloning of the breakpoints should allow cloning of the NF1 gene itself. This should be eminently achievable using the physical mapping approach combined with chromosome jumping. Once the breakpoints are cloned, the NF1 transcript will be identified by screening of appropriate cDNA libraries, and its tissue distribution studied. The genetic basis of NF1 will be investigated by analysis of this locus and its mRNA product in affected individuals. Finally, we will attempt to define the function of the normal gene by DNA transfer experiments into cultured cell lines and transgenic mice.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
2R01NS023410-04
Application #
3406848
Study Section
Neurology C Study Section (NEUC)
Project Start
1986-04-01
Project End
1994-03-31
Budget Start
1989-04-01
Budget End
1990-03-31
Support Year
4
Fiscal Year
1989
Total Cost
Indirect Cost
Name
University of Michigan Ann Arbor
Department
Type
Schools of Medicine
DUNS #
791277940
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
Gutmann, D H; Cole, J L; Collins, F S (1995) Expression of the neurofibromatosis type 1 (NF1) gene during mouse embryonic development. Prog Brain Res 105:327-35
Legius, E; Hall, B K; Wallace, M R et al. (1994) Ten base pair duplication in exon 38 of the NF1 gene. Hum Mol Genet 3:829-30
Gutmann, D H; Cole, J L; Stone, W J et al. (1994) Loss of neurofibromin in adrenal gland tumors from patients with neurofibromatosis type I. Genes Chromosomes Cancer 10:55-8
Hajra, A; Martin-Gallardo, A; Tarle, S A et al. (1994) DNA sequences in the promoter region of the NF1 gene are highly conserved between human and mouse. Genomics 21:649-52
Gregory, P E; Gutmann, D H; Mitchell, A et al. (1993) Neurofibromatosis type 1 gene product (neurofibromin) associates with microtubules. Somat Cell Mol Genet 19:265-74
Gutman, D H; Andersen, L B; Cole, J L et al. (1993) An alternatively-spliced mRNA in the carboxy terminus of the neurofibromatosis type 1 (NF1) gene is expressed in muscle. Hum Mol Genet 2:989-92
Legius, E; Marchuk, D A; Collins, F S et al. (1993) Somatic deletion of the neurofibromatosis type 1 gene in a neurofibrosarcoma supports a tumour suppressor gene hypothesis. Nat Genet 3:122-6
Andersen, L B; Fountain, J W; Gutmann, D H et al. (1993) Mutations in the neurofibromatosis 1 gene in sporadic malignant melanoma cell lines. Nat Genet 3:118-21
Colman, S D; Collins, F S; Wallace, M R (1993) Characterization of a single base-pair deletion in neurofibromatosis type 1. Hum Mol Genet 2:1709-11
Gutmann, D H; Boguski, M; Marchuk, D et al. (1993) Analysis of the neurofibromatosis type 1 (NF1) GAP-related domain by site-directed mutagenesis. Oncogene 8:761-9

Showing the most recent 10 out of 38 publications